Analystreport

Oncomed Pharmaceuticals Inc (NASDAQ: OMED) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

ONCOMED PHARMACEUTICALS  (OMED) 
Last oncomed pharmaceuticals earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: oncomed.com/invest/index.cfm